Showing 34,802 results

How HIV works

HIV Likely Evolved to Enter Latent State Because This Fuels Survival

Editor's pick
AIDSMeds
2 March 2015
PrEP

Why should WE pay for gays to have unsafe sex?

Editor's pick
Daily Mail
2 March 2015
PrEP

New Zealand: Caution urged on new HIV prevention info

Editor's pick
GayNZ
2 March 2015
Hepatitis C treatment

Delay HCV Tx and Watch Patients Die

Editor's pick
MedPage Today
2 March 2015
Hepatitis C treatment

Doctor Panel to Weigh Hepatitis C Drugs’ Costs in Guidelines

Editor's pick
Bloomberg
2 March 2015
The search for a cure

Doctor who cured ‘Berlin patient’ of HIV: ‘We knew we were doing something very special’

Editor's pick
Fred Hutch News
2 March 2015
Retention & linkage to care

New York City Gets Its HIV Act Together

Editor's pick
MedPage Today HIV/AIDS
2 March 2015
Epidemiology & behaviour

The varied nature of the US HIV/AIDS epidemic: what makes the South so different?

Editor's pick
BMJ Group blogs
2 March 2015
Retention & linkage to care

Financial incentives did not improve linkage to care or viral suppression in US study

News
28 February 2015
PrEP

PrEP: So Effective, It's Unheard Of

Editor's pick
The Body.com
27 February 2015
Side effects

Tenofovir, boosted atazanavir and boosted lopinavir are associated with cumulative risk of developing chronic kidney disease

News
27 February 2015
Hepatitis & HIV

Two interferon-free regimens show high HCV cure rates for people with HIV and HCV co-infection

News
27 February 2015
Sex workers

HIV stigma drives sex work in Northern Kenya

Editor's pick
Key Correspondents
27 February 2015
PrEP

UNAIDS welcomes further evidence of the efficacy of antiretroviral medicines in preventing new HIV infections

Editor's pick
UNAIDS
27 February 2015
Starting treatment

Inflammation Persists Despite Very Early HIV Treatment

Editor's pick
The Body Pro
27 February 2015
HIV treatment

Tenofovir alafenamide equally effective but safer for kidneys and bones than current formulation

News
27 February 2015
Pharmaceutical industry

Gilead avoids billions in U.S. taxes on its $1,000-a-pill drug

Editor's pick
Chicago Tribune
27 February 2015
HIV prevention policy

HIV Prevention Cuts Medical Costs

Editor's pick
MedPage Today HIV/AIDS
27 February 2015
Undetectable viral load & treatment as prevention

Treatment cascades and viral load surveys show how African countries can maximise prevention benefits of HIV treatment

News
27 February 2015
Circumcision

Circumcision is reducing HIV incidence in Uganda, Rakai community study shows

News
27 February 2015
Undetectable viral load & treatment as prevention

No HIV transmissions from HIV-positive partner seen in Australian gay couples study

News
27 February 2015
Behaviour change interventions

US PEPFAR abstinence and faithfulness funding had no impact on sexual behaviour in Africa

News
26 February 2015
PrEP

HIV pill: The logic of paying £500 a month so gay men don't have to wear condoms

Editor's pick
The Independent
26 February 2015
Hepatitis C treatment

NICE guidance recommends sofosbuvir (Sovaldi, Gilead Sciences) and simeprevir (Olysio, Janssen) for treating hepatitis C

Editor's pick
NICE press release
26 February 2015